HER2-associated brain metastasis has been previously described in patients with mixed underlying tumour histology (including squamous cell carcinoma), isolated tumour site (i.e., stomach), all gastrointestinal sites of primary tumours [41,42,43]. This evidence concerns the gene ERBB2 and neoplasm.